loading

Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.45%
16.80
16.40 16.17 15.21 13.36
Operating Income/Loss
2.45%
-16.80
-16.40 -16.17 -15.21 -13.36
Nonoperating Income/Loss
9.63%
2.065
2.285 15.56 -13.65 2.153
Income/Loss From Continuing Operations Before Tax
4.40%
-14.73
-14.11 -0.61 -28.87 -11.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
4.40%
-14.73
-14.11 -0.61 -28.87 -11.20
Net Income/Loss
4.40%
-14.73
-14.11 -0.61 -28.87 -11.20
Preferred Stock Dividends And Other Adjustments
-
- 2.522 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
160.48%
26.08
10.01 0.0226 4.5771 4.572
Diluted Average Shares
160.48%
26.08
10.01 0.0226 4.5771 4.572
Basic Earnings Per Share
60.28%
-0.56
-1.41 -0.62 -6.31 -2.45
Diluted Earnings Per Share
60.28%
-0.56
-1.41 -0.62 -6.31 -2.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 2.522 - -
$85.73
price up icon 0.23%
$27.54
price up icon 0.53%
$26.25
price up icon 10.08%
$110.50
price up icon 7.16%
$143.53
price up icon 0.69%
biotechnology ONC
$337.66
price up icon 5.95%
Kapitalisierung:     |  Volumen (24h):